In different prostate cancer cell models, namely LNCaP and PacMetUT1, DHA appeared to sensitise the cells by attenuating the NF-κB survival pathway that promotes cancer cell survival, resulting in decreased cancer cell survival [69]. The gene discussed is NFKB1; the disease is prostate carcinoma.